Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2008-01-29
2008-01-29
Zucker, Paul A. (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
Reexamination Certificate
active
11619997
ABSTRACT:
Therapeutic compounds, methods, and compositions are disclosed herein. These compounds have prostaglandin EP2 activity, and are useful to treat and/or prevent glaucoma and/or ocular hypertension in a mammal.
REFERENCES:
patent: 3980700 (1976-09-01), Miyano
patent: 4806668 (1989-02-01), Raduechel et al.
patent: 6426359 (2002-07-01), Cameron et al.
patent: 46301 (1988-10-01), None
patent: 01/163779 (2001-06-01), None
patent: WO 92/02495 (1992-02-01), None
patent: WO98/27976 (1998-07-01), None
patent: WO98/58911 (1998-12-01), None
patent: WO03/074483 (2003-09-01), None
patent: WO2004/089411 (2004-10-01), None
Gac Todd S.
Ngo Vinh X.
Old David W.
Allergan Inc.
Johnson Brent A.
Voet Martin A.
Zucker Paul A.
LandOfFree
Substituted cyclopentanes or cyclopentanones as therapeutic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted cyclopentanes or cyclopentanones as therapeutic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted cyclopentanes or cyclopentanones as therapeutic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3921109